Exagen Inc (XGN)
1.42
+0.01
(+0.71%)
USD |
NASDAQ |
Apr 26, 16:00
1.42
0.00 (0.00%)
After-Hours: 20:00
Exagen Cash from Financing (TTM): -10.63M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -10.63M |
September 30, 2023 | -10.58M |
June 30, 2023 | -10.50M |
March 31, 2023 | -0.521M |
December 31, 2022 | -0.489M |
September 30, 2022 | -0.529M |
June 30, 2022 | -0.382M |
March 31, 2022 | -0.428M |
December 31, 2021 | 64.68M |
September 30, 2021 | 64.81M |
June 30, 2021 | 64.76M |
March 31, 2021 | 65.04M |
December 31, 2020 | -0.097M |
September 30, 2020 | -1.806M |
Date | Value |
---|---|
June 30, 2020 | 61.38M |
March 31, 2020 | 65.21M |
December 31, 2019 | 68.73M |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
December 31, 2015 | 10.61M |
September 30, 2015 | 7.264M |
June 30, 2015 | 7.874M |
March 31, 2015 | 4.975M |
December 31, 2014 | 8.284M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-10.63M
Minimum
Dec 2023
68.73M
Maximum
Dec 2019
24.63M
Average
-0.382M
Median
Jun 2022
Cash from Financing (TTM) Benchmarks
Fonar Corp | -8.460M |
XWELL Inc | 0.008M |
ProPhase Labs Inc | 5.757M |
Applied DNA Sciences Inc | -0.0351M |
Veracyte Inc | 2.837M |